Showing 1 - 10 of 48,958
Persistent link: https://www.econbiz.de/10000922612
roughly doubled. The price response to generic entry of brand-name products has been a source of controversy. In this paper we … estimate models of price responses to generic entry in the market for brand-name and generic drugs. We study a sample of 32 … drugs that lost patent protection during the early to mid-1980s. Our results provide strong evidence that brand-name prices …
Persistent link: https://www.econbiz.de/10012473564
roughly doubled. The price response to generic entry of brand-name products has been a source of controversy. In this paper we … estimate models of price responses to generic entry in the market for brand-name and generic drugs. We study a sample of 32 … drugs that lost patent protection during the early to mid-1980s. Our results provide strong evidence that brand-name prices …
Persistent link: https://www.econbiz.de/10014158702
Persistent link: https://www.econbiz.de/10012439514
Persistent link: https://www.econbiz.de/10011405941
Persistent link: https://www.econbiz.de/10013040759
pharmaceuticals to examine how incumbents respond to change in the threat of entry. In line with the entry deterrence motive …
Persistent link: https://www.econbiz.de/10012285099
Persistent link: https://www.econbiz.de/10011617439
pharmaceuticals. We present a theoretical model with price-sensitive and loyal consumers that shows that a decrease in the reference …This paper evaluates the impact of reference pricing on prices and co-payments in the (German) market for off-patent … price affects the consumers' co-payments in a non-monotonic way: For high reference prices, a marginally lower reference …
Persistent link: https://www.econbiz.de/10010489291
Persistent link: https://www.econbiz.de/10010193836